Telehealth CEO charged in alleged $100 million scheme to provide "easy access" to Adderall, other stimulants
CBSN
Federal prosecutors have charged the CEO and head doctor of Done Global — a telehealth company that distributes stimulant drugs to thousands of patients across the United States — with fraud in an alleged $100 million scheme to provide "easy access" to Adderall and other stimulants.
Ruthia He, the founder of Done Global, was arrested in Los Angeles on Thursday over allegations she participated in the distribution of Adderall over the internet, submitted false and fraudulent claims for reimbursements and obstructed justice, the Department of Justice said in a news release. David Brody, the company's clinical president, was arrested in San Rafael, California, on the same charges.
"They generated over $100 million in revenue by arranging for the prescription of over 40 million pills," said Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the Justice Department's Criminal Division, in the statement, adding these were the Justice Department's "first criminal drug distribution prosecutions related to telemedicine prescribing through a digital health company."
